Skip to content
Open access

Association Between the Chinese Visceral Adiposity Index-Frailty Index (CVAI-FI) and the Incidence of New-Onset Stroke in Individuals with Cardiovascular-Kidney-Metabolic Syndrome Stage 0–3: Evidence From a National Population-Based Study

Oct 2026 · Global Heart · Vol 21 · 0 citations · 43 references
Medicine

TL;DR

The CVAI-FI index provides enhanced stroke risk stratification across CKM syndrome stages 0–3, with quantifiable improvements in discrimination and reclassification, and support CVAI-FI’s clinical utility for identifying high-risk individuals requiring intensified preventive interventions within emerging CKM syndrome frameworks.

Abstract

Objective: Cardiovascular-Kidney-Metabolic (CKM) syndrome represents a multisystem disorder linking metabolic dysfunction with cardiovascular complications. While the Chinese Visceral Adiposity Index (CVAI) and Frailty Index (FI) independently predict adverse outcomes, their combined utility for stroke prediction across CKM syndrome stages 0–3 remains unexplored. Methods: We analyzed 6,772 participants aged ≥45 years from the China Health and Retirement Longitudinal Study (2011–2020). Participants were classified into CKM stages 0–3, excluding stage 4 or baseline stroke. CVAI was calculated using age, BMI, waist circumference, triglycerides, and HDL-C. FI incorporated 32 health deficits following standardized methodology. The CVAI-FI index was derived as the product of CVAI and FI. Cumulative exposure was assessed in 4,170 participants with measurements from Waves 1 (2011) and 3 (2015). Multivariable logistic regression evaluated associations with incident stroke, adjusting for sociodemographic, behavioral, and clinical confounders. Model performance was assessed using ROC curves, with incremental value determined through NRI and IDI. Restricted cubic splines characterized dose-response relationships. Results: During follow-up, 447 participants (6.6%) developed stroke. CVAI-FI demonstrated a significant dose-response association with stroke risk (P for nonlinearity <0.001). Each one-SD increment in CVAI-FI corresponded to 31% higher stroke risk (OR 1.31, 95% CI 1.20–1.43). Cumulative CVAI-FI achieved superior discrimination (AUC 0.675) compared to standalone CVAI (0.616), FI (0.609), and baseline CVAI-FI (0.641, all P < 0.001), with significant IDI (0.018–0.020) and NRI (0.032) improvements. Associations remained robust across subgroups, with stronger effects among individuals with secondary education or above (OR 1.83) and those without hypertension (OR 1.51). Conclusions: The CVAI-FI index provides enhanced stroke risk stratification across CKM syndrome stages 0–3, with quantifiable improvements in discrimination and reclassification. Cumulative exposure assessment further strengthens predictive accuracy. These findings support CVAI-FI’s clinical utility for identifying high-risk individuals requiring intensified preventive interventions within emerging CKM syndrome frameworks.

Read PDF

Similar papers

Open access Oct 2026

Association between Chinese Visceral Adiposity Index and cardiovascular events in patients with cardiovascular kidney-metabolic syndrome stages 0–3: a longitudinal analysis based on CHARLS

The Chinese Visceral Adiposity Index (CVAI) demonstrates a stronger association with metabolic diseases, cardiovascular diseases (CVD), and diabetic complications in Asian populations compared to other adiposity indices. However, the association of CVAI with cardiovascular events in cardiovascular-kidney-metaboli...

C. Yating, Z. Chang, X.-C. Liu et al. · 0 citations
Open access Oct 2026

Association of Combined Cardiometabolic and Muscle Impairment Index with Cardiovascular-Kidney-Metabolic Syndrome Progression Among Middle-Aged and Older Adults: A Prospective Two-Cohort Study

Introduction: Advanced cardiovascular-kidney-metabolic (CKM) syndrome portends poor cardiovascular outcomes. The cardiometabolic index (CMI) and muscle-loss index (MLI) independently reflect metabolic and cardiovascular risk, but their combined effect on CKM syndrome remains unexplored. We aimed to evaluate the associa...

Zi-Shun Liu, Xiao-Ying Ren, Chang Su et al. · 1 citation
Open access Sep 2026

Metabolic syndrome score and cardiovascular disease risk in adults with cardiovascular-kidney-metabolic syndrome stages 0–3: A prospective cohort study

Background The American Heart Association (AHA) introduced the Cardiovascular-Kidney-Metabolic (CKM) syndrome framework, emphasizing the interplay of metabolic risk factors, chronic kidney disease, and cardiovascular disease (CVD). Whether the metabolic syndrome (MetS) score—a simple count of metabolic abnormalities—pr...

Li-Xin Cao, Dan Luo, Shuang Liu et al. · 0 citations
Open access Sep 2026

Antecedent, landmark, and two-visit cumulative triglyceride-glucose index and non-traditional lipid measures in relation to incident cardiovascular disease in adults with cardiovascular-kidney-metabolic syndrome (CKM) stages 0–3: a nationwide prospective cohort study

Higher two-visit cumulative TyG-nTLP burden was associated with incident CVD after accounting for competing death, and incremental discrimination was small, and shared laboratory components limit claims of biological independence or synergy.

Ao Lu, Qian Xu · 0 citations
Review Open access Oct 2026

Dietary inflammatory index and body shape index and mortality risk in early-stage cardiovascular–kidney–metabolic syndrome: evidence from NHANES

Cardiovascular-kidney-metabolic (CKM) syndrome is a newly recognized multisystem disorder encompassing metabolic dysfunction, chronic kidney disease, and cardiovascular disease, with most individuals remaining in early stages (0–3). Chronic inflammation and abnormal adipose tissue distribution are central to CKM...

Yi-Han Wang, Yue Qiao, Wei Wang et al. · 0 citations
Open access Sep 2026

Comparative associations of cumulative cholesterol-HDL-glucose index and triglyceride-glucose index with risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study

Investigating the impact of cumulative CHG index on CVD development in individuals with CKM syndrome stages 0–3 and compared the predictive performances of triglyceride-glucose (TyG) index and CHG index for CVD suggests that longitudinal monitoring of CHG index and TyG index may provide additional information for CVD r...

Jiabaili Wang, Qian Liu, Meng-Hui Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.